相似文献
1
Anti-gastric cancer active immunity induced by FasL/B7-1 gene-modified tumor cells.
World J Gastroenterol. 2005 Jun 7;11(21):3204-11. doi: 10.3748/wjg.v11.i21.3204.
2
Adenovirus-mediated FasL gene transfer into human gastric carcinoma.
World J Gastroenterol. 2005 Jun 14;11(22):3446-50. doi: 10.3748/wjg.v11.i22.3446.
3
Therapeutic anti-tumor response induced with epitope-pulsed fibroblasts genetically engineered for B7.1 expression and IFN-gamma secretion.
Int J Cancer. 2000 Aug 1;87(3):427-33. doi: 10.1002/1097-0215(20000801)87:3<427::aid-ijc18>3.0.co;2-j.
4
Expression of B7 costimulation molecules by colorectal cancer cells reducestumorigenicity and induces anti-tumor immunity.
World J Gastroenterol. 1999 Apr;5(2):147-151. doi: 10.3748/wjg.v5.i2.147.
5
Purification of antigenic peptide from murine hepatoma cells recognized by Class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocytes induced with B7-1-gene-transfected hepatoma cells.
J Hepatol. 1999 Jun;30(6):1119-29. doi: 10.1016/s0168-8278(99)80268-2.
6
Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccines.
World J Gastroenterol. 2003 Oct;9(10):2182-5. doi: 10.3748/wjg.v9.i10.2182.
7
In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
Cancer Gene Ther. 2004 Mar;11(3):237-48. doi: 10.1038/sj.cgt.7700678.
8
Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice.
Vaccine. 2008 Nov 5;26(47):5928-34. doi: 10.1016/j.vaccine.2008.08.051. Epub 2008 Sep 13.
9
Expression of FasL by tumor cells does not abrogate anti-tumor CTL function.
Immunol Lett. 2004 Feb 15;91(2-3):119-26. doi: 10.1016/j.imlet.2003.10.010.
10
Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street.
Blood. 1997 Sep 1;90(5):1952-9.
引用本文的文献
1
Oncolytic virus: A catalyst for the treatment of gastric cancer.
Front Oncol. 2022 Nov 24;12:1017692. doi: 10.3389/fonc.2022.1017692. eCollection 2022.
2
Comprehensive understanding of B7 family in gastric cancer: expression profile, association with clinicopathological parameters and downstream targets.
Int J Biol Sci. 2020 Jan 1;16(4):568-582. doi: 10.7150/ijbs.39769. eCollection 2020.
3
IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells.
J Mol Med (Berl). 2007 Jul;85(7):707-21. doi: 10.1007/s00109-007-0205-2. Epub 2007 Jun 15.
本文引用的文献
1
The Fas signalling pathway and its role in the pathogenesis of cancer.
Curr Opin Pharmacol. 2004 Aug;4(4):321-6. doi: 10.1016/j.coph.2004.03.008.
2
Identification of differentially expressed genes in murine mesothelioma cell lines of differing tumorigenicity using suppression subtractive hybridization.
Biochim Biophys Acta. 2004 Apr 5;1688(3):237-44. doi: 10.1016/j.bbadis.2003.12.008.
3
Expression of FasL by tumor cells does not abrogate anti-tumor CTL function.
Immunol Lett. 2004 Feb 15;91(2-3):119-26. doi: 10.1016/j.imlet.2003.10.010.
4
A novel ELISPOT assay to enhance detection of antigen-specific T cells employing antigen-presenting cells expressing vector-driven human B7-1.
J Immunol Methods. 2003 Aug;279(1-2):183-92. doi: 10.1016/s0022-1759(03)00185-6.
5
Expression of mutant non-cleavable Fas ligand on retrovirus packaging cells causes apoptosis of immunocompetent cells and improves prodrug activation gene therapy in a malignant glioma model.
Life Sci. 2003 Aug 22;73(14):1847-60. doi: 10.1016/s0024-3205(03)00542-3.
6
Localization of transfected B7-1 (CD80) DNA in human melanoma cells after particle-mediated gene transfer.
Cancer Genet Cytogenet. 2003 Jul 15;144(2):106-11. doi: 10.1016/s0165-4608(02)00940-8.
7
Enhanced immune response to DNA-based HPV16L1 vaccination by costimulatory molecule B7-2.
Antiviral Res. 2003 Jun;59(1):61-5. doi: 10.1016/s0166-3542(03)00031-7.
8
A recombinant vector expressing transgenes for four T-cell costimulatory molecules (OX40L, B7-1, ICAM-1, LFA-3) induces sustained CD4+ and CD8+ T-cell activation, protection from apoptosis, and enhanced cytokine production.
Cell Immunol. 2003 Mar;222(1):45-57. doi: 10.1016/s0008-8749(03)00080-7.
9
Cells behaving badly: a theoretical model for the Fas/FasL system in tumour immunology.
Math Biosci. 2002 Sep-Oct;179(2):113-29. doi: 10.1016/s0025-5564(02)00120-7.
10
The biological role of the Fas/FasL system during tumor formation and progression.
Semin Cancer Biol. 2002 Aug;12(4):309-15. doi: 10.1016/s1044-579x(02)00017-2.
Zotero 插件